17 – 21 March 2026

AD/PD™ 2026 Alzheimer’s & Parkinson’s Diseases Conference

AD/PD™ 2026 Alzheimer’s & Parkinson’s Diseases Conference

March 17-21, 2026 | Copenhagen, Denmark

Avance Clinical will attend AD/PD 2026 from March 17-21, 2026, in Copenhagen, Denmark.

At this world-class scientific forum dedicated to advancing therapies for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders, our team will connect with biotechs focused on accelerating clinical development in neurology and explore how our CNS Center of Excellence supports efficient, scientifically grounded CNS trial execution from early to Late phase.

Why Partner with Avance Clinical?

Biotechs developing therapies for neurological conditions face unique and persistent challenges, including complex protocol design, difficult enrollment pathways, and high screen‑failure rates.

Our CNS Center of Excellence is purpose‑built to help biotechs address these issues through:

  • Access to neurobiology, clinical strategy, regulatory affairs, site optimization, toxicology, and CRO operations within a single integrated team
  • Practical, scientifically driven protocol design tailored to neurological indications
  • Strategies to overcome recruitment barriers and reduce screen failure
  • Access to CNS‑specialized investigative sites across global regions, operational models that anticipate feasibility risks early and increase predictability
  • Integrated support from early‑phase research through pivotal global programs.

With more than 50 CNS trials completed in the past five years, our center delivers the expertise, technical capability, and operational discipline required to navigate the complex landscape of CNS research.

Connect With Our Team at AD/PD 2026

At AD/PD 2026, you can connect with two of our key CNS experts, Francesco Bibbiani, MD, VP & CNS Therapeutic Area Head, and Marty Kraut, PhD, PMP, CNS Program Operations Specialist, who together bring deep scientific, clinical, and operational expertise across global neuroscience programs.

They would welcome the opportunity to meet during AD/PD 2026 for conversations about your current or upcoming neuroscience programs.

Schedule a meeting today to learn how our CNS Center of Excellence can help shape smarter, more feasible, and more patient-focused CNS clinical development strategies.

Francesco Bibbiani

Francesco Bibbiani

Vice President & Therapeutic Area Head

Francesco Bibbiani's LinkedIn Profile

Read more

Marty Kraut Ph.D.

Marty Kraut Ph.D.

Director of Operations CNS, Centre of Excellence

Marty Kraut Ph.D.'s LinkedIn Profile

Read more

Book a meeting
Terms and conditions

Related Events